These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 16984600

  • 1. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM, Yu J, Khoury T, Chadha KS, Iyer RV, Foster J, Kuvshinoff BW, Gibbs JF, Geradts J, Black JD, Brattain MG.
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis.
    Kim HJ, Lee KT, Kim EK, Sohn TS, Heo JS, Choi SH, Choi DI, Lee JK, Paik SW, Rhee JC.
    J Gastroenterol Hepatol; 2004 May; 19(5):582-8. PubMed ID: 15086604
    [Abstract] [Full Text] [Related]

  • 4. Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.
    Noordhuis MG, Eijsink JJ, Ten Hoor KA, Roossink F, Hollema H, Arts HJ, Pras E, Maduro JH, Reyners AK, de Bock GH, Wisman GB, Schuuring E, van der Zee AG.
    Clin Cancer Res; 2009 Dec 01; 15(23):7389-97. PubMed ID: 19920104
    [Abstract] [Full Text] [Related]

  • 5. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC, Hsu C, Kao HL, Jeng YM.
    Cancer Lett; 2006 Apr 08; 235(1):34-9. PubMed ID: 16125303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
    Sonobe M, Nakagawa M, Takenaka K, Katakura H, Adachi M, Yanagihara K, Otake Y, Wada H, Tanaka F.
    J Surg Oncol; 2007 Jan 01; 95(1):63-9. PubMed ID: 17192868
    [Abstract] [Full Text] [Related]

  • 11. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.
    Hum Pathol; 2009 Dec 01; 40(12):1706-14. PubMed ID: 19683330
    [Abstract] [Full Text] [Related]

  • 12. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
    Mizoguchi M, Betensky RA, Batchelor TT, Bernay DC, Louis DN, Nutt CL.
    J Neuropathol Exp Neurol; 2006 Dec 01; 65(12):1181-8. PubMed ID: 17146292
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
    DiGiovanna MP, Stern DF, Edgerton SM, Whalen SG, Moore D, Thor AD.
    J Clin Oncol; 2005 Feb 20; 23(6):1152-60. PubMed ID: 15718311
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J, Kim JH, Paeng JY, Kim MJ, Hong SD, Lee JI, Hong SP.
    J Clin Pathol; 2005 Nov 20; 58(11):1199-205. PubMed ID: 16254112
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO.
    Cancer; 2007 May 15; 109(10):2016-24. PubMed ID: 17394193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.